首页> 外文OA文献 >Lenalidomide combined with intensive chemotherapy in acute myeloid leukemia and higher-risk myelodysplastic syndrome with 5q deletion. Results of a phase II study by the Groupe Francophone Des Myélodysplasies

【2h】

Lenalidomide combined with intensive chemotherapy in acute myeloid leukemia and higher-risk myelodysplastic syndrome with 5q deletion. Results of a phase II study by the Groupe Francophone Des Myélodysplasies

机译：来那度胺联合强化化疗可治疗急性髓样白血病和高危型骨髓增生异常综合症（5q缺失）。法语国家集团的二期研究的结果

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
引文网络
相似文献
相关主题

摘要

International audience

机译：国际观众

著录项

作者
Adès, Lionel; Prebet, Thomas; Stamatoullas, Aspasia; Recher, Christian; Guiéze, Romain; Raffoux, Emmanuel; Bouabdallah, Krimo; Hunault, Mathilde; Wattel, Eric; Stalnikiewicz, Laure; Toma, Andrea; Dombret, Hervé; Vey, Norbert; Sebert, Marie; Gardin, Claude; Chaffaut, Cendrine; Chevret, Sylvie; Fenaux, Pierre,;
展开▼
作者单位

展开▼
年度 2017
总页数
原文格式 PDF
正文语种 en
中图分类

相似文献

外文文献
中文文献
专利

1. Lenalidomide combined with intensive chemotherapy in acute myeloid leukemia and higher-risk myelodysplastic syndrome with 5q deletion. Results of a phase II study by the Groupe Francophone Des Myélodysplasies [J] . Lionel Ades, Thomas Prebet, Aspasia Stamatoullas, Haematologica . 2017,第4期

机译：来那度胺联合强化化疗可治疗5q缺失的急性髓细胞白血病和高危骨髓增生异常综合征。法语国家集团的二期研究的结果
2. Randomized Phase II Study of Azacitidine Alone or in Combination With Lenalidomide or With Vorinostat in Higher-Risk Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia: North American Intergroup Study SWOG S1117 [J] . Sekeres Mikkael A., Othus Megan, List Alan F., Journal of Clinical Oncology . 2017,第24期

机译：单独或与Lenalidomide或与vorinostat的随机氨基氨基或与vorinostat在更高风险的骨髓增生综合征和慢性骨髓细胞白血病中的随机期II研究：北美互动学习扫帚S1117
3. A phase II study of guadecitabine in higher-risk myelodysplastic syndrome and low blast count acute myeloid leukemia after azacitidine failure [J] . Marie Sébert, Aline Renneville, Cécile Bally, Haematologica . 2019,第8期

机译：阿扎胞苷衰竭后高危骨髓增生异常综合征和低原始细胞计数急性髓细胞性白血病中瓜地他滨的II期研究
4. Azanudeoside DNA Methyltransferase Inhibitor Drugs: Update on Clinical Applications in Myelodysplastic Syndromes and Acute Myeloid Leukemia [C] . Michael Lubbert, Michael Daskalakis, Philipp N. Ser, Weissenburg Symposium Biriciana . 2016

机译：硫代稳产苷DNA甲基转移酶抑制剂药物：更新骨髓增生综合征和急性髓性白血病的临床应用
5. Myelodysplastic Syndrome Progression to Acute Myeloid Leukemia at the Stem Cell Level [D] . Chen, Jiahao. 2018

机译：在干细胞水平上骨髓增生异常综合征进展为急性髓细胞性白血病
6. Lenalidomide combined with intensive chemotherapy in acute myeloid leukemia and higher-risk myelodysplastic syndrome with 5q deletion. Results of a phase II study by the Groupe Francophone Des Myélodysplasies [O] . Lionel Ades, Thomas Prebet, Aspasia Stamatoullas, 2017

机译：来那度胺联合强化化疗可治疗急性髓样白血病和高危型骨髓增生异常综合症（5q缺失）。法语国家集团的二期研究的结果
7. Lenalidomide combined with intensive chemotherapy in acute myeloid leukemia and higher-risk myelodysplastic syndrome with 5q deletion. Results of a phase II study by the Groupe Francophone Des Myélodysplasies [O] . Adès, Lionel, Prebet, Thomas, Stamatoullas, Aspasia, 2017

机译：来那度胺联合强化化疗可治疗急性髓样白血病和高危型骨髓增生异常综合症（5q缺失）。法语国家集团的二期研究的结果
8. Chemotherapy in a Transplantable Myeloid Leukemia in Brown Norway Rats: Studies on BNML as a Model for Human Acute Myeloid Leukemia [R] . Golly, L. P. 1980

机译：Brown Norway大鼠可移植骨髓性白血病的化疗：BNmL作为人类急性髓性白血病模型的研究

Lenalidomide combined with intensive chemotherapy in acute myeloid leukemia and higher-risk myelodysplastic syndrome with 5q deletion. Results of a phase II study by the Groupe Francophone Des Myélodysplasies

摘要

著录项

引文网络

相似文献

相关主题

期刊订阅